Synopsys, Inc. $SNPS Stake Reduced by Monolith Management Ltd

Monolith Management Ltd reduced its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 17.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,570 shares of the semiconductor company’s stock after selling 20,285 shares during the quarter. Synopsys comprises about 16.5% of Monolith Management Ltd’s portfolio, making the stock its 2nd biggest position. Monolith Management Ltd’s holdings in Synopsys were worth $43,952,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Sowell Financial Services LLC increased its holdings in Synopsys by 2.0% during the 4th quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after purchasing an additional 21 shares during the period. Natural Investments LLC boosted its position in Synopsys by 4.6% during the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock valued at $226,000 after acquiring an additional 21 shares in the last quarter. Financial Management Professionals Inc. boosted its position in Synopsys by 7.0% during the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock valued at $157,000 after acquiring an additional 22 shares in the last quarter. Foronjy Financial LLC boosted its position in Synopsys by 5.2% during the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after acquiring an additional 22 shares in the last quarter. Finally, Barden Capital Management Inc. boosted its position in Synopsys by 1.2% during the 4th quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock valued at $877,000 after acquiring an additional 23 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys announced a collaboration with Murata Manufacturing that expands access to Murata simulation models through Synopsys/Ansys electromagnetic and thermal analysis tools, which could support broader product adoption and reinforce Synopsys’ software ecosystem. Murata Collaborates with Synopsys to Provide Simulation Models Through Ansys Electromagnetic and Thermal Analysis Tools
• Neutral Sentiment: A DCF-based valuation article said SNPS appears “fairly valued” at about $394, suggesting the stock may not be dramatically undervalued despite recent weakness. SNPS Fairly Valued by DCF at $394
• Negative Sentiment: CEO Sassine Ghazi sold 14,603 shares for about $6.7 million, and CFO Shelagh Glaser also sold 3,394 shares for about $1.5 million. Both transactions were made under pre-arranged 10b5-1 plans, which makes them less alarming, but insider selling can still pressure sentiment. Top Synopsys Executive Makes Major Move With Insider Stock Sale

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by company insiders.

Synopsys Stock Down 1.3%

Synopsys stock opened at $448.38 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock has a market capitalization of $85.86 billion, a price-to-earnings ratio of 103.79, a PEG ratio of 2.67 and a beta of 1.22. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73. The business has a fifty day moving average price of $475.78 and a 200-day moving average price of $461.46.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have issued reports on the company. HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price on the stock. in a research report on Friday, February 20th. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Morgan Stanley increased their target price on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. BNP Paribas Exane increased their target price on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Nine equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $563.81.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.